Overview
- 6 FDA inspections are on record.
- 1 inspection produced a Form 483.
- The most recent recorded inspection date is 2025-10-24.
At a glance
Inspections
6
Form 483s
1
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 20 Oct 2025 – 24 Oct 2025 | Human Drugs | 483 | View 483 → |
| 24 Feb 2021 – 26 Feb 2021 | Human Drugs | Clean | |
| 11 Feb 2016 – 18 Feb 2016 | Human Drugs | Clean | |
| 13 Feb 2013 – 26 Feb 2013 | Human Drugs | Clean | |
| 16 Aug 2011 | Not recorded | Clean | |
| 5 Jan 2010 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
24 Oct 2025
21 CFR 211.110(a)
Control procedures to monitor and validate performance
Cited by Angela C Welker
Investigators
FDA investigators tied to this site in the record.
Angela C Welker1 insp.
Norman K Starks1 insp.
Vioela J Caze1 insp.
Nicholas P Diorio1 insp.
Brian D Nicholson1 insp.
Kathleen S Tormey1 insp.
Bruce H Mccullough1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Frontida Biopharm, LLC's 1 Form 483
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat